Cargando…
Progesterone receptor blockade in human breast cancer cells decreases cell cycle progression through G2/M by repressing G2/M genes
BACKGROUND: The synthesis of specific, potent progesterone antagonists adds potential agents to the breast cancer prevention and treatment armamentarium. The identification of individuals who will benefit from these agents will be a critical factor for their clinical success. METHODS: We utilized te...
Autores principales: | Clare, Susan E., Gupta, Akash, Choi, MiRan, Ranjan, Manish, Lee, Oukseub, Wang, Jun, Ivancic, David Z., Kim, J. Julie, Khan, Seema A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878043/ https://www.ncbi.nlm.nih.gov/pubmed/27215412 http://dx.doi.org/10.1186/s12885-016-2355-5 |
Ejemplares similares
-
Progesterone receptor antagonists reverse stem cell expansion and the paracrine effectors of progesterone action in the mouse mammary gland
por: Ranjan, Manish, et al.
Publicado: (2021) -
Mechanisms of transcriptional repression of cell-cycle G(2)/M promoters by p63
por: Testoni, Barbara, et al.
Publicado: (2006) -
Mechanisms of transcriptional repression of cell-cycle G2/M promoters by p63
por: Testoni, Barbara, et al.
Publicado: (2014) -
Embelin-induced apoptosis of HepG2 human hepatocellular carcinoma cells and blockade of HepG2 cells in the G2/M phase via the mitochondrial pathway
por: TAGHIYEV, ASAF, et al.
Publicado: (2012) -
Editor's Note on ‘Mechanisms of transcriptional repression of cell-cycle G(2)/M promoters by p63’
Publicado: (2023)